paav hsyn dio mcherry vector (Addgene inc)
Structured Review
Paav Hsyn Dio Mcherry Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 595 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paav+hsyn+dio+mcherry+vector/pAAV-hSyn-DIO-mCherry+(Plasmid+%2350459)/pm41895668-45-28-30
Average 96 stars, based on 595 article reviews
Images
Related Articles
shRNA:Article Title: Somatostatin-induced modulation of microglial activity contributes to mitigating Alzheimer's disease pathology. Article Snippet: Somatostatin (SST) is a neuropeptide widely expressed in the central nervous system, known to exert inhibitory effects through the activation of G protein-coupled somatostatin receptors (SSTRs).. Although its synaptic and network-level functions have been implicated in various neurological disorders, the direct peptidergic actions of SST—particularly on microglia—remain poorly understood.. Given that SST levels are reduced in Alzheimer’s disease (AD) and that microglia predominantly express SSTR2, we hypothesized that SST modulates microglial function in both physiological and AD-related contexts. Clone Assay:Article Title: Somatostatin-induced modulation of microglial activity contributes to mitigating Alzheimer's disease pathology. Article Snippet: Somatostatin (SST) is a neuropeptide widely expressed in the central nervous system, known to exert inhibitory effects through the activation of G protein-coupled somatostatin receptors (SSTRs).. Although its synaptic and network-level functions have been implicated in various neurological disorders, the direct peptidergic actions of SST—particularly on microglia—remain poorly understood.. Given that SST levels are reduced in Alzheimer’s disease (AD) and that microglia predominantly express SSTR2, we hypothesized that SST modulates microglial function in both physiological and AD-related contexts. Plasmid Preparation:Article Title: Somatostatin-induced modulation of microglial activity contributes to mitigating Alzheimer's disease pathology. Article Snippet: Somatostatin (SST) is a neuropeptide widely expressed in the central nervous system, known to exert inhibitory effects through the activation of G protein-coupled somatostatin receptors (SSTRs).. Although its synaptic and network-level functions have been implicated in various neurological disorders, the direct peptidergic actions of SST—particularly on microglia—remain poorly understood.. Given that SST levels are reduced in Alzheimer’s disease (AD) and that microglia predominantly express SSTR2, we hypothesized that SST modulates microglial function in both physiological and AD-related contexts. |
